Table 1.
Baseline variables, patients’ demographics, coagulative function, comorbidities, renal function, and lesion’s characteristics
| Variables | On clamp | Off clamp | p value |
|---|---|---|---|
| Males, no. (%) | 85 (69.1) | 88 (69.8) | 1 |
| Age (yr), median (IQR) | 61.0 (50.5–70.0) | 60.0 (52.2–68.8) | 0.7 |
| BMI, median (IQR) | 26.4 (24.2–29.0) | 26.8 (24.4–29.3) | 0.5 |
| Platelet count, median (IQR) | 232k (186k–278k) | 226.5k (188k–270k) | 0.7 |
| Hb (g/dl), median (IQR) | 14.0 (13.0–14.8) | 14.3 (13.4–15.2) | 0.03 |
| % Hct, median (IQR) | 42.3 (40.1–44.2) | 43.0 (41.4–45.0) | 0.07 |
| PT (s), median (IQR) | 95.0 (88.0–99.0) | 95.5 (88.0–99.0) | 0.8 |
| PTT (s), median (IQR) | 30.0 (28.2–35.8) | 29.7 (28.0–35.9) | 0.3 |
| Hypertension, no. (%) | 62 (50.4) | 77 (61.6) | 0.1 |
| Diabetes, no. (%) | 25 (20.3) | 25 (20.3) | 1 |
| Cardiac disease, no. (%) | 13 (11.1) | 14 (11.6) | 1 |
| Vasculopathy, no. (%) | 15 (12.3) | 20 (16.4) | 0.5 |
| ECOG performance status, no. (%) | 1 | ||
| 0 | 95 (77.9) | 96 (76.8) | |
| 1 | 24 (19.7) | 25 (20) | |
| ≥2 | 3 (2.5) | 4 (3.2) | |
| Charlson’s Comorbidity Index, no. (%) | 0.8 | ||
| 0 | 62 (51.2) | 62 (50) | |
| 1 | 12 (9.9) | 13 (10.5) | |
| 2 | 11 (9.1) | 14 (11.3) | |
| >2 | 36 (29.7) | 35 (28.2) | |
| SCr (mg/dl), median (IQR) | 0.9 (0.8–1.0) | 0.9 (0.8–1.0) | 0.6 |
| eGFR (ml/min), median (IQR) | 90.0 (71.0–99.0) | 90.0 (70.0–99.0) | 0.8 |
| % Split renal function, median (IQR) | 45.0 (30.0–52.0) | 45.0 (39.5–52.2) | 0.3 |
| Clinical tumor size (cm), median (IQR) | 3.0 (2.6–4.5) | 3.0 (2.3–4.1) | 0.3 |
| RENAL score, median (IQR) | 6.0 (5.0–8.0) | 6.0 (5.0–7.0) | 0.8 |
BMI = body mass index; ECOG = Eastern Cooperative Oncology Group; eGFR = estimated glomerular filtration rate; Hb = hemoglobin; Hct = hematocrit; IQR = interquartile range; PT = prothrombin time; PTT = partial thromboplastin time; SCr = serum creatinine.